|
Facebook
Twitter
Linkedin
|
Elekta Holds First Meeting of the MOSAIQ RTP Particle Therapy Global Council
| Company News - Elekta Group |
Elekta, a human care company pioneering significant innovations and clinical solutions for treating cancer and neurological conditions, announces the successful conclusion of the 1st meeting of the MOSAIQ Radiation Treatment Planning (RTP) Particle Therapy Global Council.
Set within the wonderful Scenery of Courmayeur in the Italian Alps, the goal and achievement of the meeting was to develop robust planning tools in all Particle Therapy environments including Protons and Carbon ions within the MOSAIQ RTP framework. A collaborative discussion placed strong emphasis on Workflow Optimization and Integration with the EMR and how to improve Outcome Analysis and Evidence Based Medicine in Particle Therapy.
The council included representatives from industry leaders in the Particle Therapy field including Elekta and IBA, as well as innovators from ProCure, Trento, Oklahoma, NIRS-Japan and the University of Tuebingen. Participation from additional Particle Therapy leading centers is expected for the next Council meeting to be held during the 48th PTCOG in Heidelberg, Germany, September 2009.
The support of IBA Particle Therapy was greatly appreciated by members of the Elekta Group including Elekta Oncology, Impac Software, and CMS Software. The success of the meeting confirms the leadership of the two companies in the continuous development of a common strategy in the Particle Therapy field.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated state of the art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care. For More information about Elekta,please visit www.elekta.com.
About IBA
IBA develops and markets leading edge technologies, pharmaceuticals and tailor-made solutions for healthcare with a focus on cancer diagnosis and therapy. Leveraging on its scientific expertise, IBA is also active in the field of industrial sterilization and ionization. Listed on the pan-European stock exchange EURONEXT, IBA is included in the BelMid Index. (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). Website: www.iba-worldwide.com
Source: Elekta
The council included representatives from industry leaders in the Particle Therapy field including Elekta and IBA, as well as innovators from ProCure, Trento, Oklahoma, NIRS-Japan and the University of Tuebingen. Participation from additional Particle Therapy leading centers is expected for the next Council meeting to be held during the 48th PTCOG in Heidelberg, Germany, September 2009.
The support of IBA Particle Therapy was greatly appreciated by members of the Elekta Group including Elekta Oncology, Impac Software, and CMS Software. The success of the meeting confirms the leadership of the two companies in the continuous development of a common strategy in the Particle Therapy field.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated state of the art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care. For More information about Elekta,please visit www.elekta.com.
About IBA
IBA develops and markets leading edge technologies, pharmaceuticals and tailor-made solutions for healthcare with a focus on cancer diagnosis and therapy. Leveraging on its scientific expertise, IBA is also active in the field of industrial sterilization and ionization. Listed on the pan-European stock exchange EURONEXT, IBA is included in the BelMid Index. (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). Website: www.iba-worldwide.com
Source: Elekta











